Alberta Investment Management Corp (AIMCo)’s AMAG Pharmaceuticals AMAG Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-37,100	Closed	-$742K	–	859
2018 Q3	$742K	Sell	37,100 -23,700	-39%	-$540K	0.01%	666
2018 Q2	$1.19M	Sell	60,800 -4,800	-7%	-$106K	0.01%	558
2018 Q1	$1.32M	Buy	65,600 +15,600	+31%	+$264K	0.01%	511
2017 Q4	$663K	Sell	50,000 -17,600	-26%	-$265K	0.01%	607
2017 Q3	$1.25M	Buy	67,600 +35,100	+108%	+$654K	0.01%	521
2017 Q2	$598K	Hold	32,500	–	–	0.01%	621
2017 Q1	$733K	Buy	+32,500	New	+$778K	0.01%	647

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s AMAG Position: Q4 2018 in Review

Alberta Investment Management Corp (AIMCo) sold out of AMAG Pharmaceuticals (AMAG) in Q4 2018, closing a stake of 37,100 shares — an estimated $742K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in AMAG in Q1 2017 and held it in 7 quarters. The position peaked at $1.32M in Q1 2018. 190 funds tracked by Wall St. Rank hold AMAG as of Q4 2018.

Alberta Investment Management Corp (AIMCo) reported no remaining AMAG Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 37,100 AMAG Pharmaceuticals shares in Q4 2018, an estimated $742K.
Alberta Investment Management Corp (AIMCo) first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 7 quarters.
Alberta Investment Management Corp (AIMCo)'s AMAG Pharmaceuticals position peaked at $1.32M in Q1 2018.
190 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2018.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2018, filed 14 Feb 2019.